Prognostic impact of RAASi and MRA Use in de novo HFrEF Patients with Renal Dysfunction and Hyperkalemia: Insights from the COEDO-AHF Registry"
Event:
ESC Congress 2025
Topic:
Pharmacotherapy
Session:
Novel therapies in heart failure: impact on outcomes
